The FDA has approved Lipfendra, the first oral PCSK9 inhibitor, for the treatment of high cholesterol. Two medical experts explain why this matters.
Merck said on Thursday the U.S. FDA has approved its cholesterol pill, the first of its kind to receive the health ...
Scientists at @HopkinsMedicine say they found a class of inhibitors that may lead to better, more effective treatments for ...
Patients who take a calcium-channel blocker for high blood pressure and then receive a prescription for clarithromycin, one ...